Evidence map›Paper›PMID 26047514›Full record

ArticlePloS one2015

The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer.

Lei Chen, Jing Yang, Mingyue Zheng, Xiangyin Kong, Tao Huang, Yu-Dong Cai

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Lei ChenCollege of Life Science, Shanghai University, Shanghai, 200444, People's Republic of China; College of Information Engineering, Shanghai Maritime University, Shanghai, 201306, People's Republic of China.
Jing YangInstitute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, People's Republic of China.
Mingyue ZhengDrug Discovery and Design Center, Shanghai Institute of Materia Medica, Shanghai, 201203, People's Republic of China.
Xiangyin KongInstitute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, People's Republic of China.
Tao HuangInstitute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, People's Republic of China.
Yu-Dong CaiCollege of Life Science, Shanghai University, Shanghai, 200444, People's Republic of China.
Shanghai Institutes for Biological Sciences · CNShanghai University · CNChinese Academy of Sciences · CNShanghai Institute of Materia Medica · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer causes over one million deaths every year worldwide. However, prevention and treatment methods for this serious disease are limited. The identification of new chemicals related to lung cancer may aid in disease prevention and the design of more effective treatments. This study employed a weighted network, constructed using chemical-chemical interaction information, to identify new chemicals related to two types of lung cancer: non-small lung cancer and small-cell lung cancer. Then, a randomization test as well as chemical-chemical interaction and chemical structure information were utilized to make further selections. A final analysis of these new chemicals in the context of the current literature indicates that several chemicals are strongly linked to lung cancer.

Indexed as

AnimalsAntineoplastic AgentsArsenicalsBerberineCarcinogenesisCarcinoma, Non-Small-Cell LungColchicineDaunorubicinDigoxinDrug DiscoveryHumansLungLung NeoplasmsOuabainPrednisoneSmall Cell Lung CarcinomaAntineoplastic AgentsArsenicalsBerberineColchicineDaunorubicinDigoxinmonomethylarsonic acidOuabainPrednisoneTretinoin

Identifiers

PMID26047514
PMCPMC4457841
OpenAlexW1801406214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.